Showing results (801-810 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|December 13, 2018
Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in JapanShingo Kato, Takuo Hayashi, Yoshiyuki Suehara, et al.
Japanese Journal of Clinical Oncology|February 24, 2018
Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patientsDanila Coradini, Annalisa Orenti, Elisabetta Venturelli, et al.
Japanese Journal of Clinical Oncology|March 1, 1987
Primary leiomyosarcoma in the breastM Yamashina
Japanese Journal of Clinical Oncology|March 1, 1987
Extramedullary plasmacytoma of the mediastinumK Niwa, T Tanaka, H Mori, et al.
Japanese Journal of Clinical Oncology|June 21, 2022
Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up studyHiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, et al.
Japanese Journal of Clinical Oncology|June 21, 2022
Higher proportions of a healthy gastric mucosa in healthy Japanese adults with later birth year: analysis of 41 957 participantsYoko Saito, Shogo Kikuchi
Japanese Journal of Clinical Oncology|June 21, 2022
Clinicopathological characteristics and prognosis of resectable lung adenosquamous carcinoma: a population-based study of the SEER databaseTengyong Wang, Jian Zhou, Yaxin Wang, et al.
Japanese Journal of Clinical Oncology|June 24, 2022
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)Shigehira Saji, Shozo Ohsumi, Mitsuya Ito, et al.
Japanese Journal of Clinical Oncology|November 18, 2020
Current status and perspectives of immune checkpoint inhibitors for colorectal cancerHidekazu Hirano, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Japanese Journal of Clinical Oncology|November 18, 2020
Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter StudyYoshinori Handa, Yasuhiro Tsutani, Takahiro Mimae, et al.
Pageof 534